Michael S Wyzga's Net Worth

$13 Million

Who is Michael S Wyzga?

Michael S Wyzga has an estimated net worth of $13 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Altus Pharmaceuticals Inc., EXACT SCIENCES CORP, Radius Health, Inc., Invivyd, Inc., LogicBio Therapeutics, Inc., Akebia Therapeutics, Inc., X4 Pharmaceuticals, Inc, OncoMed Pharmaceuticals Inc, and IDENIX PHARMACEUTICALS INC.

SEC CIK

Michael S Wyzga's CIK is 0001201256

Past Insider Trading and Trends

2007 was Michael S Wyzga's most active year for acquiring shares with 7 total transactions. Michael S Wyzga's most active month to acquire stocks was the month of May. 2011 was Michael S Wyzga's most active year for disposing of shares, totalling 14 transactions. Michael S Wyzga's most active month to dispose stocks was the month of March. 2010 saw Michael S Wyzga paying a total of $2,202,480.00 for 57,750 shares, this is the most they've acquired in one year. In 2011 Michael S Wyzga cashed out on 2,101,105 shares for a total of $36,884,585.00, their largest year based on trade value.